Wegovy Self-Pay Program

Not Funded

About

Uninsured or self-pay patients can access Wegovy at reduced pricing through NovoCare Pharmacy. $149/month for 1.5 mg and 4 mg doses. New patients get introductory pricing of $199/month for first 2 months of starter doses.

Insurance requirements: Uninsured, Self-Pay

As low as: $149 per mo

Enrollment Forms

Enroll in Self-Pay Program

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Enrollment Required: Yes

•Coverage Required: No

•Needs Based: No

•Activation Required: Yes

Let us handle your prior authsJust enter your patient's info and we'll:

Verify eligibility with the payer.
Pull the right PA forms directly from the payer.
Submit, track & send live updates to your dashboard.

Utilize patient records to autofill forms with our AI in seconds.

Free to start · HIPAA compliant

Enrollment Forms

Enroll in Self-Pay Program

Let us handle your prior authsJust enter your patient's info and we'll:

Verify eligibility with the payer.
Pull the right PA forms directly from the payer.
Submit, track & send live updates to your dashboard.

Utilize patient records to autofill forms with our AI in seconds.

Free to start · HIPAA compliant

Other Programs

HealthWell Foundation: MASH

Wegovy at no costSee program details for eligibility

NovoCare Pharmacy Home Delivery

Wegovy at no costSee program details for eligibility

Other Tools for Wegovy

Check medication interactions

Get prior authorization forms

Get patient education materials

Frequently Asked Questions (FAQ)

The Wegovy Savings Offer from Novo Nordisk lets eligible commercially insured patients pay as little as $25 per month, with savings up to $100 per month. Patients with Medicare or Medicaid coverage can't use the savings offer but may qualify for the HealthWell Foundation MASH or PAN Foundation MASH programs (Wegovy at no cost, eligibility-dependent). Open the program cards above for the option that matches your patient.

Yes — the Wegovy Savings Offer from Novo Nordisk. Eligible patients with commercial insurance pay as little as $25 per month, up to $100 per month in savings. Patients on Medicare or Medicaid aren't eligible for the savings offer but may qualify for the HealthWell Foundation MASH or PAN Foundation MASH program (Wegovy at no cost for eligible patients). See the program cards above for current terms.

PrescriberPoint surfaces Novo Nordisk's self-pay options for uninsured patients: the Wegovy Self-Pay Program for the oral tablet is as low as $149 per month, and the injectable self-pay program is as low as $349 per month. Commercially insured patients can use the Wegovy Savings Offer instead — as little as $25 per month, up to $100 per month in savings. Open the program cards above to compare every option for your patient.

There are paths for every coverage type. Commercially insured patients → Wegovy Savings Offer ($25/month, up to $100/month in savings). Medicare or Medicaid patients → HealthWell Foundation MASH or PAN Foundation MASH (no cost for eligible patients). Uninsured patients → Wegovy Self-Pay Program ($149/month oral tablet, $349/month injectable). The program cards above show each option with its eligibility and enrollment link.